The online seminar with a basic overview of the market access, clinical evidence, value claims management and health economics for the Med Tech non-market access professionals
Available as pre-recorded webinar or full presentation in Acrobat PDF
Market access was and remains incredibly important for the commercial success of medical technologies. The complexity of market access is also explained by the overlap of different complex areas, including regulatory, clinical epidemiology, health economics, biomedical statistics and health policy. The field of market access became very hard to understand for people from other areas, including marketing, business, clinical and regulatory affairs.
This seminar is designed by the industry leader in education in European market access to support Med Tech professionals outside the narrow circle of market access specialists. This seminar is designed specifically for non-market access professionals, who want to understand the area of market access better, but do not need to become a topical expert on market access. The seminar consists of four main blocks: value claims, development of clinical evidence, development of economic evidence, and market access.
The seminar is dedicated specifically to medical technologies.
You will learn all key concepts in claims management, clinical evidence, health economics and market access and will be able to better understand the goals of market access activities, instruments used, key drivers and barriers.
The seminar is available in the form of a presentation in Acrobat PDF (89 slides) and a pre-recorded webinar (2.5-long).
Key terms and concepts, five access hurdles for medical technology, “Quadruple Aim”, understanding needs of different stakeholders, value claims management process, examples of substantiated and unsubstantiated value claims
Biases in clinical studies and how to tackle them, the hierarchy of evidence, systematic literature reviews and meta-analyses, PICOS approach for research questions, development of clinical research program, evidence requirements of different stakeholders, post-market evidence generation, real-world evidence, a typical pathway to develop evidence, presentation of evidence, the structure of value dossier
Dimensions of health economic outcome, types of health economic analysis, sources of economic evidence, the importance of patient-reported outcome measures (PROMs), the concept of the quality-adjusted life years (QALYs), the concept of incremental cost-effectiveness ratio, willingness-to-pay threshold, need for health economic evidence, economic evidence requirements for reimbursement processes
Definition of market access, key terms, types of financing of health care systems, key payment mechanisms, basics of diagnosis-related groups (DRGs), add-on reimbursement for medical technologies, classification of procedures, reimbursement pathway for medical technologies, pricing considerations in market access, introduction to health technology assessment (HTA), innovation funding, value-based health care, stakeholder management in market access
One option is to watch the seminar, which is provided as a pre-recorded webinar. The duration of the webinar is 2 hours and 30 minutes. Seminar is available for 6 months
You can also access just the educational material - the full presentation of the seminar in Acrobat PDF (89 slides)
This 2-minute extract presents overview of key market access terminology